APAF Apixaban in Atrial Fibrillation Registry

• Conditions: Atrial Fibrillation; I48.0; Paroxysmal atrial fibrillation

• Registration Number: DRKS00011080
• Lead Sponsor: IHF GmbH - Institut für Herzinfarktforschung

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-09-21
• Study Completion: 2018-08-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 5015

Inclusion Criteria

Age =18 years
- Non-valvular atrial fibrillation
- In hospitals or specialized or non-specialised office-based centres
- Written informed consent for participation in observational study (incl. telephone follow-ups)
- Not simultaneously participating in any randomized trial

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
- Comparison of antithrombotic therapy for atrial fibrillation: Prescribed drugs; time frame: 12 months; Name of antithrombotic drug<br>